PRTN3 and rheumatoid arthritis: Thus, an explanation for the larger proportion of IFNα-positive patients in SLE relative to RA may be that autoantibodies in SLE target endogenous nucleic acids that may be more potent than RF and ACPA in stimulating IFNα protein production.